Report on recent use of PET-CT in lymphoma in the 54th ASH annual meeting
10.3760/cma.j.issn.1009-9921.2013.01.005
- VernacularTitle:PET-CT在淋巴瘤中应用的最新进展:第54届美国血液学会年会深度报道
- Author:
Jiazhu WU
;
Wei XU
;
Jianyong LI
- Publication Type:Journal Article
- Keywords:
Lymphoma;
PET-CT;
ASH annual meeting
- From:
Journal of Leukemia & Lymphoma
2013;22(1):11-12,16
- CountryChina
- Language:Chinese
-
Abstract:
Positron emission tomography-computed tomography (PET-CT) with both anatomic and functional information is now widely utilized for most lymphoma subtypes,among which,the pretreatment staging and response assessment of PET-CT in Hodgkin lymphoma (HL) and diffuse large B-cell lymphoma (DLBCL)have been well documented.Multiple clinical trials are ongoing using PET-CT for therapy monitoring.Additionally,factors interpreting interim PET (PET-i) like visual analysis using Deauville 5-PS,metabolic tumor volume at baseline (MTV0),and △ SUVmaxPET0-i show different prognostic values.However,the management of PET-CT in lymphoma is still elusive,further trials remain to be done to get evidences for the use of PET-CT in guiding therapeutic decisions.
